OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
KIR Receptors as Key Regulators of NK Cells Activity in Health and Disease
Joanna Dębska-Zielkowska, Grażyna Moszkowska, Maciej Zieliński, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1777-1777
Open Access | Times Cited: 75
Joanna Dębska-Zielkowska, Grażyna Moszkowska, Maciej Zieliński, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1777-1777
Open Access | Times Cited: 75
Showing 1-25 of 75 citing articles:
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Wenkang Wang, Yang Liu, Zhen He, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 49
Wenkang Wang, Yang Liu, Zhen He, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 49
Immune determinants of endometrial receptivity: a biological perspective
Sarah A. Robertson, Lachlan M. Moldenhauer, Ella S. Green, et al.
Fertility and Sterility (2022) Vol. 117, Iss. 6, pp. 1107-1120
Open Access | Times Cited: 68
Sarah A. Robertson, Lachlan M. Moldenhauer, Ella S. Green, et al.
Fertility and Sterility (2022) Vol. 117, Iss. 6, pp. 1107-1120
Open Access | Times Cited: 68
Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy
Seungyong Shin, Pyunghwajun Lee, Jieun Han, et al.
Tissue Engineering and Regenerative Medicine (2023) Vol. 20, Iss. 3, pp. 371-387
Open Access | Times Cited: 24
Seungyong Shin, Pyunghwajun Lee, Jieun Han, et al.
Tissue Engineering and Regenerative Medicine (2023) Vol. 20, Iss. 3, pp. 371-387
Open Access | Times Cited: 24
Unleashing the power of immune checkpoints: Post-translational modification of novel molecules and clinical applications
Jie Wang, Yian Wang, Xianjie Jiang, et al.
Cancer Letters (2024) Vol. 588, pp. 216758-216758
Closed Access | Times Cited: 14
Jie Wang, Yian Wang, Xianjie Jiang, et al.
Cancer Letters (2024) Vol. 588, pp. 216758-216758
Closed Access | Times Cited: 14
Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses
Jordan A. Hartmann, Marcella R. Cardoso, Maria Cecília Ramiro Talarico, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2393-2410.e14
Closed Access | Times Cited: 9
Jordan A. Hartmann, Marcella R. Cardoso, Maria Cecília Ramiro Talarico, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2393-2410.e14
Closed Access | Times Cited: 9
The role of extravillous trophoblasts and uterine NK cells in vascular remodeling during pregnancy
Xiaowei Wei, Yu-Chen Zhang, Fan Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Xiaowei Wei, Yu-Chen Zhang, Fan Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
Kerry A. Whalen, Kavya Rakhra, Naveen K. Mehta, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Kerry A. Whalen, Kavya Rakhra, Naveen K. Mehta, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 19
A novel inhibitor of PGK1 suppresses the aerobic glycolysis and proliferation of hepatocellular carcinoma
Mingfeng Li, Aotong Zhang, Xin Qi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114115-114115
Open Access | Times Cited: 20
Mingfeng Li, Aotong Zhang, Xin Qi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114115-114115
Open Access | Times Cited: 20
Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities
Yongfeng Chen, Jing Li, Linglong Xu, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 2, pp. 268-291
Open Access | Times Cited: 12
Yongfeng Chen, Jing Li, Linglong Xu, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 2, pp. 268-291
Open Access | Times Cited: 12
Identification of the crucial roles of BAXhigh NK cells in human derived mesenchymal stem cell therapy for chronic heart failure patients
Pengfei Zhang, Yuanfeng Xin, Hui Yuan, et al.
Pathology - Research and Practice (2025), pp. 155924-155924
Closed Access
Pengfei Zhang, Yuanfeng Xin, Hui Yuan, et al.
Pathology - Research and Practice (2025), pp. 155924-155924
Closed Access
Immunity at maternal–fetal interface: KIR /HLA (Allo)recognition*
Marina Alexandrova, Diana Manchorova, Tanya Dimova
Immunological Reviews (2022) Vol. 308, Iss. 1, pp. 55-76
Closed Access | Times Cited: 19
Marina Alexandrova, Diana Manchorova, Tanya Dimova
Immunological Reviews (2022) Vol. 308, Iss. 1, pp. 55-76
Closed Access | Times Cited: 19
Molecular Aspects of Resistance to Immunotherapies—Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma
Aleksandra Kusowska, Matylda Kubacz, Marta Krawczyk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1501-1501
Open Access | Times Cited: 17
Aleksandra Kusowska, Matylda Kubacz, Marta Krawczyk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1501-1501
Open Access | Times Cited: 17
Alloimmune Causes of Recurrent Pregnancy Loss: Cellular Mechanisms and Overview of Therapeutic Approaches
Cristina Uţa, Alexandru Tîrziu, Elena-Larisa Zimbru, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1896-1896
Open Access | Times Cited: 3
Cristina Uţa, Alexandru Tîrziu, Elena-Larisa Zimbru, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1896-1896
Open Access | Times Cited: 3
Natural Killer Cell Education in Women With Recurrent Pregnancy Loss
Amber Lombardi, Denise H. J. Habets, Salwan Al‐Nasiry, et al.
American Journal of Reproductive Immunology (2025) Vol. 93, Iss. 2
Open Access
Amber Lombardi, Denise H. J. Habets, Salwan Al‐Nasiry, et al.
American Journal of Reproductive Immunology (2025) Vol. 93, Iss. 2
Open Access
kir‐mapper: A Toolkit for Killer‐Cell Immunoglobulin‐Like Receptor (KIR ) Genotyping From Short‐Read Second‐Generation Sequencing Data
Erick C. Castelli, Raphaela Neto Pereira, Gabriela Sato Paes, et al.
HLA (2025) Vol. 105, Iss. 3
Closed Access
Erick C. Castelli, Raphaela Neto Pereira, Gabriela Sato Paes, et al.
HLA (2025) Vol. 105, Iss. 3
Closed Access
The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances
Paula Morcillo-Martín-Romo, Javier Valverde-Pozo, María Ortiz-Bueno, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 857-857
Open Access
Paula Morcillo-Martín-Romo, Javier Valverde-Pozo, María Ortiz-Bueno, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 857-857
Open Access
Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis
Pamela McCombe, Todd A. Hardy, Robert J. Nona, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Pamela McCombe, Todd A. Hardy, Robert J. Nona, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors
Chuandong Hou, Zining Wang, Xuechun Lu
Cancer Pathogenesis and Therapy (2023) Vol. 2, Iss. 1, pp. 24-30
Open Access | Times Cited: 9
Chuandong Hou, Zining Wang, Xuechun Lu
Cancer Pathogenesis and Therapy (2023) Vol. 2, Iss. 1, pp. 24-30
Open Access | Times Cited: 9
Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients
José L. Casado, Elisa Moraga, Pilar Vizcarra, et al.
Viruses (2021) Vol. 14, Iss. 1, pp. 46-46
Open Access | Times Cited: 19
José L. Casado, Elisa Moraga, Pilar Vizcarra, et al.
Viruses (2021) Vol. 14, Iss. 1, pp. 46-46
Open Access | Times Cited: 19
Natural killer cells and killer cell immunoglobulin-like receptors in solid organ transplantation: Protectors or opponents?
Mina Roshan Zamir, Abbas Shahi, Saeedeh Salehi, et al.
Transplantation Reviews (2022) Vol. 36, Iss. 4, pp. 100723-100723
Closed Access | Times Cited: 14
Mina Roshan Zamir, Abbas Shahi, Saeedeh Salehi, et al.
Transplantation Reviews (2022) Vol. 36, Iss. 4, pp. 100723-100723
Closed Access | Times Cited: 14
Activating KIR/HLA-I combinations as a risk factor of adult B-ALL
Hossein Halimi, Sara Mirzazadeh, Kurosh Kalantar, et al.
Human Immunology (2024) Vol. 85, Iss. 2, pp. 110750-110750
Closed Access | Times Cited: 2
Hossein Halimi, Sara Mirzazadeh, Kurosh Kalantar, et al.
Human Immunology (2024) Vol. 85, Iss. 2, pp. 110750-110750
Closed Access | Times Cited: 2
CD155 as an emerging target in tumor immunotherapy
Jiang‐Wan Wu, Ying Liu, Xing‐Jie Dai, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111896-111896
Closed Access | Times Cited: 2
Jiang‐Wan Wu, Ying Liu, Xing‐Jie Dai, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111896-111896
Closed Access | Times Cited: 2
Nature Killer Cell for Solid Tumors: Current obstacles and prospective remedies in NK cell therapy and beyond
Jia‐Hao Tao, Jun Zhang, Huashun Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 205, pp. 104553-104553
Closed Access | Times Cited: 2
Jia‐Hao Tao, Jun Zhang, Huashun Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 205, pp. 104553-104553
Closed Access | Times Cited: 2
KIR-HLA gene diversities and susceptibility to lung cancer
Marjan Hematian Larki, Elham Ashouri, Shaghik Barani, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Marjan Hematian Larki, Elham Ashouri, Shaghik Barani, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Driving natural killer cell-based cancer immunotherapy for cancer treatment: An arduous journey to promising ground
Dandan Jiang, Jingya Zhang, Zhenkun Mao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115004-115004
Open Access | Times Cited: 5
Dandan Jiang, Jingya Zhang, Zhenkun Mao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115004-115004
Open Access | Times Cited: 5
